Recent advances in tissue-engineered corneal regeneration

Similar documents
Agenzia Italiana del Farmaco

Wider Adoption of Regenerative Medicine Driven by Open Innovation

Patient Handbook on Stem Cell Therapies

European Regenerative Medicine Firms & Their Strategic Approaches. Michael Morrison University of York

NEXT GENERATION ECM-BASED ALLOGRAFT TECHNOLOGY:

Stem Cell Principle -

Stem cell dialogue: key findings, conclusions and recommendations. Dr Darren Bhattachary, Director BMRB

Des cellules-souches dans le poumon : pourquoi faire?

Stem cells and motor neurone disease

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications

Future implications of regenerative medicine on assisted reproductive technology. Regenerative medicine. History of Regenerative medicine

Recent Progress in ips Cell Research and Application

Stephen Strom (Cell Transplantation and Regenerative Medicine, KI) Stem Cell Therapy of Liver Disease

Tissue Engineered Medical Products

The Effects of Scaffold Rigidity on Retinal Pigment Epithelial Cells. Corina White Symposium on Biomaterials Science 24 October 2016

Updates on global movement in regulation of Advanced Therapeutics

A bibliometric trend analysis of stem cells and regenerative medicine research output in Iran: comparison with the global research output

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

The Review Section Table (Overview)

Stem Cells and Regenerative Medicine

Regulatory Updates on Cellular Therapy Products in Japan

Production Assistance for Cellular Therapies PACT

History and Recent Advances of Stem Cell Biology and the Implications for Human Health

Worldwide unique: Boy is given new skin thanks to gene therapy

Fujifilm s Initiatives in Regenerative Medicine

Regenerative medicine in the United Kingdom

From Stem Cell to Any Cell

Regulating Cell Therapy: An Ex-Regulators Perspective

Medicyte GmbH. Infinity Gets Cultured. European Business Development Conference, Dresden October 2014 Björn F. Lindemann, CEO

Introduction This is an exam style question on stem cells that might be useful towards the end of the topic.

Collagen Solutions Plc

Application of Hydrogels in Ocular Tissue Engineering

۱۵ BIOCHEMISTRY & MOLECULAR BIOLOGY

Advanced-therapy medicinal products: new competencies in hospital pharmacy Seminar PH4. Relevant Financial Relationships - None

Introduction to Cell- Biomaterial Engineering!

ADDIS ABABA UNIVERSITY CENTER OF BIOMEDICAL ENGINEERING

Insight to Gene Techno Science Co.,Ltd

Cell and Gene Therapy Catapult preclinical database

Clinical Trials in Taiwan Regulatory Achievement and Current Status

Embryonic Stem Cell Research Oversight Committee (ESCRO) Application Form

-Regulation (EC) No.1394/2007 -Regulation (EC) No. 668/2009

Enhancement of the Mechanical and Biological Properties of a Biomembrane for Tissue Engineering the Ocular Surface

Relative cost of hepatocytes

Chamber Temperature Measurement of Micro PCR Chip Using Thermocouple

Chapter 20: Biotechnology

Versatility and performance of Lipofectamine Stem Transfection Reagent

Research Article The Effect of Negative Poisson s Ratio Polyurethane Scaffolds for Articular Cartilage Tissue Engineering Applications

6 Pillar Approach Parafascicular Surgery of the White Matter

PACT. PACT Program. Production Assistance for Cellular Therapies

Historical Background and Scientific Foundations

REIMAGINING DRUG DEVELOPMENT:

Comparison of hydrogen storage properties of pure Mg and milled pure Mg

Holland Innovation Network Team Boston: Walter de Wit Julia Knoeff

InVivo Therapeutics. Developing Innovative Products for Spinal Cord Injury

General Guidelines. In this sense, contribution of distinct individuals to the outcome of scientific analysis needs to be properly acknowledged.

Germany Tissue Engineered - Skin Substitutes Market Outlook to 2020

Embryonic Stem Cell Research Oversight (ESCRO) Committee. Policies and Procedures

GMO Technology Conference

Symposium INTERNATIONAL SCIENTIFIC SYMPOSIUM: WHAT S NEW IN REFRACTIVE EYE SURGERY

Stem Cell Services. Driving Innovation for Stem Cell Researchers

Functional Assessment and Clinical Outcome

COMMISSION OF THE EUROPEAN COMMUNITIES. Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

Research Xchange Forum 2018

Nanotechnology and Advanced Materials for more effective Healthcare

Activities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of Korea

Horizon 2020 funding opportunities for Regenerative Medicine ( ) Rudolf Fryček, PhD.

STEERING COMMITTEE FOR THE UK STEM CELL BANK AND FOR THE USE OF STEM CELL LINES

Healthcare Technology Assessment Division HTAD of the International Federation for Medical and Biological Engineering IFMBE

Development of non-substantially manipulated cell-based ATMPs 1 : flexibility introduced via the application of the risk-based approach

Adipose rabbit mesenchymal stem cells for the treatment of the chronic scar tissue of the vocal cords

Clinical Research: A Multifaceted Discipline

8. Clinical Trial Assessment Phase II

Regulatory Pathways for Rare Diseases

Medical Standards. These Standards have the approval of the Eye Banking Committee of the American Academy of Ophthalmology.

Case Study: Examples Relating to the Quality Control of Cell-based Products

ReproRNA -OKSGM is a non-integrating, self-replicating RNA-based reprogramming vector for generating induced pluripotent stem (ips)

1. Materials Challenges in Regenerative Medicine

MEDPOR. Orbital Floor

REPORT OF THE IBC WORKING GROUP ON HUMAN CLONING AND INTERNATIONAL GOVERNANCE

The 3Rs: are Human Stem Cells and Organs on Chip alternatives?

Transcription:

4 Special Issue: Positioning of Tissue Engineering in Regenerative Medicine Review Article Recent advances in tissue-engineered corneal regeneration Eun Young Kim 1), Jeong Eun Song 1), Chan Hum Park 2), Choun-Ki Joo 3) and Gilson Khang 1, ) 1) Department of PolymerNano Science & Technology, Department of BIN Fusion Technology and Polymer BIN Fusion Research Center, Chonbuk National University, Jeonju, Korea 2) Department of Otorhinolaryngology-Head and Neck Surgery, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Gangwon, Korea 3) Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Gangnam St. Mary Hospital, Seoul, Korea There are many dystrophies related corneal endothelium resulting in edema, loss of transparency and blindness, finally. Currently, transplantation is only surgical treatment for patients with these corneal endothelial dystrophies, however, the limitation of transplantation is the absolute deficiency of donor cornea. Very recently, to overcome this issue of limited supply of donor cornea, regenerative medicine including stem cell therapy and tissue engineering has been widely attempted and success for human clinical trial. In this review, recent advances for the regeneration of corneal endothelial cell (CEnC) as (1)isolation and culture methods of CEnC for the somatic cell source, (2)stem cell source for CEnC as embryonic, induce pluripotent stem cell (ips) and adult stem cell, (3)tissue engineering techniques as cell sheet engineering and development of scaffold materials and finally (4)the application of silk as a biomaterial for cornea by our laboratory have been introduced. Rec.12/3/2013, Acc.1/7/2014, pp4-14 Correspondence should be addressed to: Gilson Khang, Department of PolymerNano Science & Technology, Department of BIN Fusion Technology and Polymer BIN Fusion Research Center, Chonbuk National University, 567 Baekje-daero, Deokjin, Jeonju, 561-756 Korea. Phone: +82-63- 270-2355, Fax: +82-63-270-2341, E-mail: gskhang@jbnu.ac.kr Key words biomaterials, cornea dystrophy, regenerative medicine, scaffolds, stem cell, tissue engineering Introduction

5 Isolation and optimization of culture methods for CEnC

6 Stem cell source for CEnC as embryonic, ips and adult stem cell

7 Fig.1 Morphological changes in derived-cencs at from 7 hrs to 6 days after direct coculture on each condition (Magnification x200) [Adapted from Ref. 28) ; Copyright permission from World Scientific Publications]. Tissue engineering techniques and development of scaffold materials 1)Cell Sheet Engineering

8 2)Scaffold Biomaterials for Corneal Reconstruction

9 Table 1 Sericin contents of silk cocoons and fabricated LSS and HSS 3) 3)Silk for Corneal Reconstruction Fig.2 Optical transparency patterns of silk fibroin films in the visible range. Dried samples were taken from Figure 1 [Adapted from Ref. 3) ; Copyright permission from Springer Publications].

10 Fig.3 Cell proliferation measurement of using the MTT assay TCP was used as a positive control. LSS and HSS show a significant difference in optical intensity ( 0.01) 5 days post-seeding compared to TCP [Adapted from Ref. 3) ; Copyright permission from Springer Publications]. Conclusion and Future Prospective Acknowledgments and Source of Funding Conflict of Interest

11

12

13

14